116 related articles for article (PubMed ID: 17496009)
1. Subtraction SPECT for parathyroid scintigraphy based on maximization of mutual information.
Hara N; Takayama T; Onoguchi M; Obane N; Miyati T; Yoshioka T; Sakaguchi K; Honda M
J Nucl Med Technol; 2007 Jun; 35(2):84-90. PubMed ID: 17496009
[TBL] [Abstract][Full Text] [Related]
2. Comparison of parathyroid imaging with technetium-99m-pertechnetate/sestamibi subtraction, double-phase technetium-99m-sestamibi and technetium-99m-sestamibi SPECT.
Chen CC; Holder LE; Scovill WA; Tehan AM; Gann DS
J Nucl Med; 1997 Jun; 38(6):834-9. PubMed ID: 9189125
[TBL] [Abstract][Full Text] [Related]
3. Preoperative parathyroid scintigraphic lesion localization: accuracy of various types of readings.
Nichols KJ; Tomas MB; Tronco GG; Rini JN; Kunjummen BD; Heller KS; Sznyter LA; Palestro CJ
Radiology; 2008 Jul; 248(1):221-32. PubMed ID: 18483228
[TBL] [Abstract][Full Text] [Related]
4. Positive
Dugonjić S; Šišić M; Radulović M; Ajdinović B
Hell J Nucl Med; 2017; 20(1):46-50. PubMed ID: 28315908
[TBL] [Abstract][Full Text] [Related]
5. The value of 99mTc-sestamibi SPECT/CT over conventional SPECT in the evaluation of parathyroid adenomas or hyperplasia.
Gayed IW; Kim EE; Broussard WF; Evans D; Lee J; Broemeling LD; Ochoa BB; Moxley DM; Erwin WD; Podoloff DA
J Nucl Med; 2005 Feb; 46(2):248-52. PubMed ID: 15695783
[TBL] [Abstract][Full Text] [Related]
6. Comparison of double-phase 99mTc-sestamibi with 123I-99mTc-sestamibi subtraction SPECT in hyperparathyroidism.
Neumann DR; Esselstyn CB; Go RT; Wong CO; Rice TW; Obuchowski NA
AJR Am J Roentgenol; 1997 Dec; 169(6):1671-4. PubMed ID: 9393188
[TBL] [Abstract][Full Text] [Related]
7. Technetium-99m tetrofosmin for parathyroid scintigraphy: a direct comparison with (99m)Tc-MIBI, (201)Tl, MRI and US.
Wakamatsu H; Noguchi S; Yamashita H; Yamashita H; Tamura S; Jinnouchi S; Nagamachi S; Futami S
Eur J Nucl Med; 2001 Dec; 28(12):1817-27. PubMed ID: 11734921
[TBL] [Abstract][Full Text] [Related]
8. Preoperative 123I/99mTc-sestamibi subtraction SPECT and SPECT/CT in primary hyperparathyroidism.
Neumann DR; Obuchowski NA; Difilippo FP
J Nucl Med; 2008 Dec; 49(12):2012-7. PubMed ID: 18997051
[TBL] [Abstract][Full Text] [Related]
9. Parathyroid 99mTc-sestamibi scintigraphy: dual-tracer subtraction is superior to double-phase washout.
Leslie WD; Dupont JO; Bybel B; Riese KT
Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1566-70. PubMed ID: 12458389
[TBL] [Abstract][Full Text] [Related]
10. Incremental diagnostic value of preoperative 99mTc-MIBI SPECT in patients with a parathyroid adenoma.
Lorberboym M; Minski I; Macadziob S; Nikolov G; Schachter P
J Nucl Med; 2003 Jun; 44(6):904-8. PubMed ID: 12791817
[TBL] [Abstract][Full Text] [Related]
11. Dual-isotope 99mTc-MIBI/123I parathyroid scintigraphy in primary hyperparathyroidism: comparison of subtraction SPECT/CT and pinhole planar scan.
Hassler S; Ben-Sellem D; Hubele F; Constantinesco A; Goetz C
Clin Nucl Med; 2014 Jan; 39(1):32-6. PubMed ID: 24152647
[TBL] [Abstract][Full Text] [Related]
12. Optimal interpretative strategy for preoperative parathyroid scintigraphy.
Bahador FM; Latifi HR; Grossman SJ; Oza UD; Xu H; Griffeth LK
Clin Nucl Med; 2015 Feb; 40(2):116-22. PubMed ID: 25525929
[TBL] [Abstract][Full Text] [Related]
13. [99m-Tc-MIBI SPECT parathyroid gland scintigraphy for the preoperative localization of small parathyroid gland adenomas].
Moka D; Voth E; Larena-Avellaneda A; Schicha H
Nuklearmedizin; 1997 Oct; 36(7):240-4. PubMed ID: 9441283
[TBL] [Abstract][Full Text] [Related]
14. Comparison of SPECT/CT, SPECT, and planar imaging with single- and dual-phase (99m)Tc-sestamibi parathyroid scintigraphy.
Lavely WC; Goetze S; Friedman KP; Leal JP; Zhang Z; Garret-Mayer E; Dackiw AP; Tufano RP; Zeiger MA; Ziessman HA
J Nucl Med; 2007 Jul; 48(7):1084-9. PubMed ID: 17574983
[TBL] [Abstract][Full Text] [Related]
15. The usefulness of neck pinhole SPECT as a complementary tool to planar scintigraphy in primary and secondary hyperparathyroidism.
Spanu A; Falchi A; Manca A; Marongiu P; Cossu A; Pisu N; Chessa F; Nuvoli S; Madeddu G
J Nucl Med; 2004 Jan; 45(1):40-8. PubMed ID: 14734671
[TBL] [Abstract][Full Text] [Related]
16. Single photon emission computed tomography (SPECT) should be routinely performed for the detection of parathyroid abnormalities utilizing technetium-99m sestamibi parathyroid scintigraphy.
Thomas DL; Bartel T; Menda Y; Howe J; Graham MM; Juweid ME
Clin Nucl Med; 2009 Oct; 34(10):651-5. PubMed ID: 19893394
[TBL] [Abstract][Full Text] [Related]
17. Limited sensitivity of parathyroid imaging with (99m)Tc-sestamibi/(123)I subtraction in an endemic goiter area.
Rink T; Schroth HJ; Holle LH; Garth H
J Nucl Med; 2002 Sep; 43(9):1175-80. PubMed ID: 12215555
[TBL] [Abstract][Full Text] [Related]
18. Parathyroid detection in secondary hyperparathyroidism with 123I/99mTc-sestamibi subtraction single photon emission computed tomography.
Neumann DR; Esselstyn CB; Madera A; Wong CO; Lieber M
J Clin Endocrinol Metab; 1998 Nov; 83(11):3867-71. PubMed ID: 9814460
[TBL] [Abstract][Full Text] [Related]
19. Parathyroid scintigraphy with 99mTc-MIBI and 123I subtraction: a comparison with magnetic resonance imaging and ultrasonography.
Wakamatsu H; Noguchi S; Yamashita H; Yamashita H; Tamura S; Jinnouchi S; Nagamachi S; Futami S
Nucl Med Commun; 2003 Jul; 24(7):755-62. PubMed ID: 12813193
[TBL] [Abstract][Full Text] [Related]
20. Parathyroid scintigraphy with 99mTc sestamibi.
Bernà L; Sitges-Serra A
Nucl Med Commun; 2003 May; 24(5):485-8. PubMed ID: 12717063
[No Abstract] [Full Text] [Related]
[Next] [New Search]
